{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:42Z","timestamp":1791560982519,"version":"4.3.4"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Obesity is increasingly prevalent among living kidney donor candidates, presenting complex clinical, ethical, and logistical challenges. Although obesity is linked to increased post-donation hypertension, diabetes, proteinuria, and chronic kidney disease, the overall absolute risks are modest and may differ depending on metabolic health and patterns of fat distribution. Current reliance on body mass index alone fails to capture the full spectrum of obesity-related risks, leading to inconsistent donor selection practices and potential inequities. This review examines the pathophysiological mechanisms of obesity-related kidney injury and available evidence on comorbidities and postdonation outcomes related to obesity. We discuss tools for better risk stratification, such as imaging-based adiposity assessment and personalized weight management strategies, and note that some risks may remain after weight loss. Barriers such as rigid body mass index cutoffs, limited access to treatment, and lack of long-term follow-up exacerbate disparities in access to donation. We argue for a shift toward individualized, risk-based evaluation supported by multidisciplinary care. We underscore the importance of donor counseling and advocate for a comprehensive, rather than paternalistic approach to living kidney donor selection. Advancing safe and equitable living donation in the context of rising obesity rates will necessitate revised guidelines, improved access to treatment, and an ongoing commitment to donor well-being.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000001030","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:00:59Z","timestamp":1771347659000},"page":"1814-1825","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Obesity in Living Kidney Donors from Risk to Ethics"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5600-4452","authenticated-orcid":false,"given":"Pooja","family":"Budhiraja","sequence":"first","affiliation":[{"name":"Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8062-4072","authenticated-orcid":false,"given":"Beata","family":"Bzoma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-5405","authenticated-orcid":false,"given":"Aleksandar","family":"Denic","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3165-5184","authenticated-orcid":false,"given":"Naim","family":"Issa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"McKee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"},{"name":"Living Kidney Donor, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Schinstock","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4149-2278","authenticated-orcid":false,"given":"Sandra J.","family":"Taler","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini A.","family":"Chakkera","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-1328","authenticated-orcid":false,"given":"Julie K.","family":"Heimbach","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-9519","authenticated-orcid":false,"given":"Caroline C.","family":"Jadlowiec","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0508-3557","authenticated-orcid":false,"given":"Kayla R.","family":"Mirie","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-4469","authenticated-orcid":false,"given":"Diwan S.","family":"Ty","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9576-5687","authenticated-orcid":false,"given":"Aleksandra","family":"Kukla","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"10431","key":"B1-20261009","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet."},{"issue":"5","key":"B2-20261009","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.111.175315","article-title":"Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study","volume":"58","author":"Foster","year":"2011","journal-title":"Hypertension."},{"issue":"5","key":"B3-20261009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"B4-20261009","doi-asserted-by":"crossref","first-page":"e13360","DOI":"10.1111\/ctr.13360","article-title":"Weight gain after kidney donation: association with increased risks of type 2 diabetes and hypertension","volume":"32","author":"Issa","year":"2018","journal-title":"Clin Transpl."},{"issue":"3","key":"B5-20261009","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.kint.2016.10.014","article-title":"Obesity increases the risk of end-stage renal disease among living kidney donors","volume":"91","author":"Locke","year":"2017","journal-title":"Kidney Int."},{"issue":"11","key":"B6-20261009","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1681\/ASN.2021040548","article-title":"Intermediate renal outcomes, kidney failure, and mortality in obese kidney donors","volume":"32","author":"Ibrahim","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B7-20261009","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/TP.0000000000002411","article-title":"Early hypertension and diabetes after living kidney donation: a national cohort study","volume":"103","author":"Holscher","year":"2019","journal-title":"Transplantation."},{"issue":"10","key":"B8-20261009","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1600-6143.2007.01932.x","article-title":"The medical evaluation of living kidney donors: a survey of US transplant centers","volume":"7","author":"Mandelbrot","year":"2007","journal-title":"Am J Transplant"},{"issue":"12","key":"B9-20261009","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/ajt.15964","article-title":"Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017","volume":"20","author":"Garg","year":"2020","journal-title":"Am J Transplant."},{"issue":"7","key":"B10-20261009","doi-asserted-by":"crossref","first-page":"e0181846","DOI":"10.1371\/journal.pone.0181846","article-title":"Attitudes among transplant professionals regarding shifting paradigms in eligibility criteria for live kidney donation","volume":"12","author":"Lafranca","year":"2017","journal-title":"PLoS One."},{"issue":"3","key":"B11-20261009","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ajt.14519","article-title":"Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors","volume":"18","author":"Naik","year":"2018","journal-title":"Am J Transplant."},{"issue":"5","key":"B12-20261009","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.surg.2019.07.008","article-title":"Donation approval among obese living kidney donor candidates: the impact of metabolic syndrome","volume":"166","author":"Mustian","year":"2019","journal-title":"Surgery."},{"issue":"3","key":"B13-20261009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"suppl 3","key":"B14-20261009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of clinical endocrinologists and American college of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract."},{"issue":"1","key":"B16-20261009","doi-asserted-by":"crossref","first-page":"31487","DOI":"10.1038\/s41598-024-83320-8","article-title":"Higher abdominal fat area associates with lower donor kidney function before and after living kidney donation","volume":"14","author":"Westenberg","year":"2024","journal-title":"Sci Rep."},{"issue":"10","key":"B17-20261009","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1007\/s00261-024-04391-9","article-title":"Renal fat deposition measured on dixon-based MRI is significantly associated with early kidney damage in obesity","volume":"49","author":"Tang","year":"2024","journal-title":"Abdom Radiol (NY)."},{"issue":"10","key":"B18-20261009","doi-asserted-by":"crossref","first-page":"e0293464","DOI":"10.1371\/journal.pone.0293464","article-title":"Para-perirenal fat thickness is associated with reduced glomerular filtration rate regardless of other obesity-related indicators in patients with type 2 diabetes mellitus","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One."},{"key":"B19-20261009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/IJNRD.S39739","article-title":"Obesity, hypertension, and chronic kidney disease","volume":"7","author":"Hall","year":"2014","journal-title":"Int J Nephrol Renovasc Dis."},{"issue":"2","key":"B20-20261009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J Vet Intern Med."},{"issue":"4","key":"B21-20261009","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int."},{"issue":"24","key":"B22-20261009","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","article-title":"Single-nephron glomerular filtration rate in healthy adults","volume":"376","author":"Denic","year":"2017","journal-title":"N Engl J Med."},{"issue":"9","key":"B23-20261009","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.ki.5001799","article-title":"Glomerular volume and renal histology in obese and Non-obese living kidney donors","volume":"70","author":"Rea","year":"2006","journal-title":"Kidney Int."},{"issue":"10","key":"B24-20261009","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1600-6143.2008.02355.x","article-title":"Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors","volume":"8","author":"Rook","year":"2008","journal-title":"Am J Transplant."},{"issue":"3","key":"B25-20261009","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1152\/ajprenal.00492.2017","article-title":"Overweight young female kidney donors have low renal functional reserve postdonation","volume":"315","author":"van Londen","year":"2018","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B26-20261009","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.kint.2020.03.038","article-title":"Podocyte stress and detachment measured in urine are related to mean arterial pressure in healthy humans","volume":"98","author":"Naik","year":"2020","journal-title":"Kidney Int."},{"issue":"6","key":"B27-20261009","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/HYPERTENSIONAHA.124.24379","article-title":"Association of podometric findings in patients with hypertension and type 2 diabetes: a retrospective analysis","volume":"82","author":"Paschen","year":"2025","journal-title":"Hypertension."},{"issue":"8","key":"B28-20261009","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/bjs\/znac114","article-title":"Risks for donors associated with living kidney donation: meta-analysis","volume":"109","author":"Bellini","year":"2022","journal-title":"Br J Surg."},{"issue":"4","key":"B29-20261009","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2215\/CJN.0000000000000403","article-title":"Central body fat distribution and kidney function after living kidney donation","volume":"19","author":"Westenberg","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B30-20261009","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/TP.0000000000003210","article-title":"Factors associated with residual kidney function and proteinuria after living kidney donation in the United States","volume":"105","author":"Augustine","year":"2021","journal-title":"Transplantation."},{"issue":"4","key":"B31-20261009","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.juro.2014.03.106","article-title":"Prospective measurement of urinary microalbumin in living kidney donor nephrectomy: toward understanding the renal functional recovery period","volume":"192","author":"Yoon","year":"2014","journal-title":"J Urol."},{"issue":"5","key":"B32-20261009","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.surg.2018.07.015","article-title":"Implications of excess weight on kidney donation: long-term consequences of donor nephrectomy in obese donors","volume":"164","author":"Serrano","year":"2018","journal-title":"Surgery."},{"issue":"9","key":"B33-20261009","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying postdonation risk of ESRD in living kidney donors","volume":"28","author":"Massie","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B34-20261009","doi-asserted-by":"crossref","first-page":"e041122","DOI":"10.1136\/bmjopen-2020-041122","article-title":"Hypertension, cardiovascular disease and cause of death in Danish living kidney donors: matched cohort study","volume":"10","author":"Chaudry","year":"2020","journal-title":"BMJ Open."},{"issue":"1","key":"B35-20261009","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/SLA.0000000000005669","article-title":"Change in body mass index and attributable risk of new-onset hypertension among obese living kidney donors","volume":"278","author":"Reed","year":"2023","journal-title":"Ann Surg."},{"issue":"11","key":"B36-20261009","first-page":"e114","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation."},{"issue":"10","key":"B37-20261009","doi-asserted-by":"crossref","first-page":"e13696","DOI":"10.1111\/ctr.13696","article-title":"Associations of obesity with antidiabetic medication use after living kidney donation: an analysis of linked national registry and pharmacy fill records","volume":"33","author":"Lentine","year":"2019","journal-title":"Clin Transplant."},{"issue":"2","key":"B38-20261009","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.06608","article-title":"Cardiovascular effects of unilateral nephrectomy in living kidney donors","volume":"67","author":"Moody","year":"2016","journal-title":"Hypertension."},{"issue":"5","key":"B39-20261009","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ndt\/gfab054","article-title":"Increased risk of ischaemic heart disease after kidney donation","volume":"37","author":"Haugen","year":"2022","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B40-20261009","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/ajt.13687","article-title":"Perioperative complications after living kidney donation: a national study","volume":"16","author":"Lentine","year":"2016","journal-title":"Am J Transplant."},{"issue":"5","key":"B41-20261009","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.mayocp.2021.11.023","article-title":"Complications after hand-assisted laparoscopic living donor nephrectomy","volume":"97","author":"Benavides","year":"2022","journal-title":"Mayo Clin Proc."},{"key":"B42-20261009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.physbeh.2013.07.009","article-title":"Biological mechanisms that promote weight regain following weight loss in obese humans","volume":"120","author":"Ochner","year":"2013","journal-title":"Physiol Behav."},{"issue":"6","key":"B43-20261009","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/ctr.12246","article-title":"Obesity as a barrier to living kidney donation: a center-based analysis","volume":"27","author":"Sachdeva","year":"2013","journal-title":"Clin Transplant."},{"issue":"5","key":"B44-20261009","doi-asserted-by":"crossref","first-page":"e13812","DOI":"10.1111\/ctr.13812","article-title":"Multiple reasons for living donor denial: a single-center experience","volume":"34","author":"Lum","year":"2020","journal-title":"Clin Transplant."},{"issue":"11","key":"B45-20261009","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.0000000760","article-title":"Obesity, underweight, and accuracy of eGFR using Cystatin C and creatinine in a Northern European Population","volume":"36","author":"Russel","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B46-20261009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clinbiochem.2017.12.002","article-title":"Triglycerides and glycated hemoglobin for screening insulin resistance in obese patients","volume":"53","author":"Boursier","year":"2018","journal-title":"Clin Biochem."},{"issue":"3","key":"B47-20261009","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med."},{"issue":"8S suppl 1","key":"B48-20261009","first-page":"S1","article-title":"KDIGO clinical practice guideline on the evaluation and care of living kidney donors","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation."},{"issue":"1","key":"B49-20261009","doi-asserted-by":"crossref","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","article-title":"Steatotic liver disease, MASLD and risk of chronic kidney disease","volume":"50","author":"Bilson","year":"2024","journal-title":"Diabetes Metab."},{"issue":"1","key":"B50-20261009","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/TP.0000000000003665","article-title":"Outcomes of kidney donors with impaired fasting glucose","volume":"106","author":"Hebert","year":"2022","journal-title":"Transplantation."},{"issue":"2","key":"B51-20261009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"B52-20261009","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1249\/MSS.0b013e3181949333","article-title":"Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults","volume":"41","author":"Donnelly","year":"2009","journal-title":"Med Sci Sports Exerc."},{"key":"B53-20261009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095319","article-title":"Obesity paradox in patients on maintenance dialysis","volume":"151","author":"Kalantar-Zadeh","year":"2006","journal-title":"Contrib Nephrol."},{"issue":"11","key":"B54-20261009","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med."},{"issue":"3","key":"B55-20261009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med."},{"issue":"1","key":"B56-20261009","doi-asserted-by":"crossref","first-page":"e13841","DOI":"10.1111\/obr.13841","article-title":"Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity","volume":"26","author":"Mechanick","year":"2025","journal-title":"Obes Rev."},{"issue":"1","key":"B57-20261009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MNH.0000000000000853","article-title":"Paradigm shift in lifestyle modification for solitary kidney after donor nephrectomy","volume":"32","author":"Tantisattamo","year":"2023","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"9","key":"B58-20261009","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.3390\/nu12092549","article-title":"Dietary protein intake and single-nephron glomerular filtration rate","volume":"12","author":"Oba","year":"2020","journal-title":"Nutrients."},{"issue":"11","key":"B59-20261009","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.3390\/jcm14113873","article-title":"Evaluation of risk factors for kidney function decline and chronic kidney disease in living kidney donors","volume":"14","author":"Oruc","year":"2025","journal-title":"J Clin Med."},{"issue":"14","key":"B60-20261009","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA."},{"issue":"13","key":"B61-20261009","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med."},{"issue":"21","key":"B62-20261009","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med."},{"issue":"3","key":"B63-20261009","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajt.2023.12.003","article-title":"Antiobesity pharmacotherapy to facilitate living kidney donation","volume":"24","author":"Orandi","year":"2024","journal-title":"Am J Transplant."},{"issue":"4","key":"B64-20261009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.soard.2019.12.022","article-title":"American society for metabolic and bariatric surgery 2018 estimate of metabolic and bariatric procedures performed in the United States","volume":"16","author":"English","year":"2020","journal-title":"Surg Obes Relat Dis."},{"issue":"15","key":"B65-20261009","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/jama.2018.14433","article-title":"Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes","volume":"320","author":"King","year":"2018","journal-title":"JAMA."},{"issue":"4","key":"B66-20261009","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int."},{"issue":"4","key":"B67-20261009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jamasurg.2024.7052","article-title":"Long-term outcomes of laparoscopic roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for obesity: the SM-BOSS randomized clinical trial","volume":"160","author":"Kraljevic","year":"2025","journal-title":"JAMA Surg."},{"issue":"1","key":"B68-20261009","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int."},{"issue":"2","key":"B69-20261009","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11695-025-07669-z","article-title":"Comparative analysis of renal function outcomes following sleeve gastrectomy and Roux-en-Y gastric bypass: a systematic review and meta-analysis","volume":"35","author":"Juca","year":"2025","journal-title":"Obes Surg."},{"issue":"3","key":"B70-20261009","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.ajkd.2016.09.020","article-title":"Estimated GFR before and after bariatric surgery in CKD","volume":"69","author":"Imam","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B71-20261009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.20897","article-title":"Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial","volume":"319","author":"Peterli","year":"2018","journal-title":"JAMA."},{"issue":"3","key":"B72-20261009","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0000000000001929","article-title":"Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized swiss multicenter bypass or sleeve study (SM-BOSS)","volume":"265","author":"Peterli","year":"2017","journal-title":"Ann Surg."},{"issue":"3","key":"B73-20261009","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/joim.12012","article-title":"Review of the key results from the Swedish Obese subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery","volume":"273","author":"Sj\u00f6str\u00f6m","year":"2013","journal-title":"J Intern Med."},{"issue":"8","key":"B74-20261009","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.soard.2020.03.034","article-title":"Weight regain after bariatric surgery: a systematic literature review and comparison across studies using a large reference sample","volume":"16","author":"King","year":"2020","journal-title":"Surg Obes Relat Dis."},{"issue":"3","key":"B75-20261009","doi-asserted-by":"crossref","first-page":"101641","DOI":"10.1016\/j.diabet.2025.101641","article-title":"Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists","volume":"51","author":"J","year":"2025","journal-title":"Diabetes Metab."},{"issue":"2","key":"B76-20261009","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ajpath.2019.10.008","article-title":"Glucagon-like peptide-1 receptor agonism improves nephrotoxic serum nephritis by inhibiting T-cell proliferation","volume":"190","author":"Moschovaki Filippidou","year":"2020","journal-title":"Am J Pathol."},{"issue":"2","key":"B77-20261009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med."},{"issue":"2","key":"B78-20261009","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jcp.30621","article-title":"Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease","volume":"237","author":"Ravindran","year":"2022","journal-title":"J Cell Physiol."},{"issue":"4","key":"B79-20261009","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med."},{"issue":"7","key":"B80-20261009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/dom.12073","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes","volume":"15","author":"Heise","year":"2013","journal-title":"Diabetes Obes Metab."},{"issue":"20","key":"B81-20261009","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med."},{"issue":"17","key":"B82-20261009","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/archinte.158.17.1855","article-title":"Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults","volume":"158","year":"1998","journal-title":"Arch Intern Med."},{"issue":"8","key":"B83-20261009","first-page":"585","article-title":"Abdominal fat distribution and coronary heart disease risk factors in men-waist\/height ratio as a simple and useful predictor","volume":"19","author":"Hsieh","year":"1995","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"3","key":"B84-20261009","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","article-title":"Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis","volume":"13","author":"Ashwell","year":"2012","journal-title":"Obes Rev."},{"issue":"8042","key":"B85-20261009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-024-08165-7","article-title":"Adipose tissue retains an epigenetic memory of obesity after weight loss","volume":"636","author":"Hinte","year":"2024","journal-title":"Nature."},{"issue":"16","key":"B86-20261009","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes Federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:36Z","timestamp":1791558096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001030"}},"subtitle":["Bridging Gaps in Evaluation and Management"],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001030","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}